Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-02-25 @ 4:57 PM
Study NCT ID:
NCT02382666
Status:
COMPLETED
Last Update Posted:
2015-08-25
First Post:
2015-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers
Sponsor:
Tesaro, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chemotherapy-induced Nausea and Vomiting | View |
Keywords: